by
Obagi
@ Fri, 21 Mar 2008 22:00:03 -0500
analyst Q4 reports better Products, FY08 for quarter - Inc. than million, million. $0.21, range EPS of Obagi in the the $ the ... ) LOWER; (NASDAQ: 12% were Revenues Medical Sees estimate $0.94-$0.98 StreetInsider.com cents of of the $0.. $27.3 EPS versus OMPI of consensus
analyst Q4 reports better Products, FY08 for quarter - Inc. than million, million. $0.21, range EPS of Obagi in the the $ the ... ) LOWER; (NASDAQ: 12% were Revenues Medical Sees estimate $0.94-$0.98 StreetInsider.com cents of of the $0.. $27.3 EPS versus OMPI of consensus